West Pharmaceutical Services, Inc. WST
392.18 USD -16.60 (-4.06%)
At closeNov 5, 2026, 4:10 PM EST
392.48 +0.30 +0.08%
After hours · Nov 5, 4:10 PM ET
392.12 Day range 409.81
223.83 52-week range 438.27
- YTD
- +42.54%
- 1 year
- +38.32%
Held by funds
393 US ETFs and mutual funds hold WST · largest positions
Ownership
Held by insiders 0.66%
Held by institutions 103.66%
Float held by institutions 104.35%
Institutions 1,245
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.55% | 6,651,784 | 2.72B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.62% | 4,613,134 | 1.89B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.76% | 4,015,766 | 1.64B | Jun 29, 2026 |
| FMR, LLC | 5.13% | 3,574,816 | 1.46B | Jun 29, 2026 |
| State Street Corporation | 4.81% | 3,348,698 | 1.37B | Jun 29, 2026 |
| Artisan Partners Limited Partnership | 3.46% | 2,411,792 | 985.51M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.22% | 2,242,860 | 916.48M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.63% | 1,830,358 | 747.92M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.20% | 1,530,738 | 625.49M | Jun 29, 2026 |
| Fidelity Contrafund | 1.61% | 1,120,323 | 457.79M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 1.35% | 940,525 | 384.32M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.35% | 937,921 | 383.25M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIRKETT BERNARD JOHN | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 17, 2025 | 7,520 |
| BUTHMAN MARK A | Director | Stock Award(Grant) | May 3, 2026 | 44,308 |
| FAVORITE ANNETTE F | Officer | Sale | Sep 14, 2026 | 21,817 |
| FEEHERY WILLIAM F. | Director | Stock Award(Grant) | May 3, 2026 | 32,519 |
| GREEN ERIC MARK | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 17, 2026 | 175,418 |
| HOFMANN THOMAS W | Director | Stock Award(Grant) | May 5, 2025 | 44,637 |